Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...

The Africa Centres for Disease Control and Prevention said the country saw a 31 per cent increase in cases last week.

THE Catholic Church has suspended the use of holy water as part of its liturgy in efforts to stop the spread of the Mpox ...

THE government has intensified surveillance and precautionary measures against Mpox after confirming two cases ...

Dar es Salaam. The Ministry of Health has confirmed two cases of Mpox, marking the first time the disease has been reported ...

In eastern Congo, mpox detection and treatment face setbacks amid a rebel offensive backed by Rwanda. Hospitals suffer from ...

The two confirmed infected individuals have symptoms such as rash, fever, and headache, as well as pain in the body and ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...